Introduction
Mobile technology may be useful in addressing several issues in adolescent diabetes management.
Purpose
To assess the feasibility and acceptability of a cell phone glucose monitoring system for adolescents with type 1 diabetes and their parents.
Methods
The authors recruited patients with type 1 diabetes who had been diagnosed for at least 1 year. Each adolescent used the system for 6 months, filling out surveys every 3 months to measure their usability and satisfaction with the cell phone glucose monitoring system, as well as how use of the system might affect quality of family functioning and diabetes management.
Results
Adolescents reported positive feelings about the technology and the service, even though a concerning number of them had significant technical issues that affected continued use of the device. Nearly all thought that the clinic involvement in monitoring testing behavior was quite acceptable. The use of the Glucophone™ did not, however, significantly change the quality of life of the adolescents, their level of conflict with their parents, their reported self-management of diabetes, or their average glycemic control within the short time frame of the study.
Conclusions
As a feasibility study of the technology, this work was successful in demonstrating that cell phone glucose monitoring technology can be used in an adolescent population to track and assist in self-monitoring behavior. The authors speculate that explicitly attempting to change behavior, perhaps with the use of behavioral contracts, would enhance the technology's ability to improve outcomes. T ype 1 diabetes is one of the most common chronic diseases of childhood. 1, 2 In spite of significant technical and medication advances in treatment over the past 2 decades, [3] [4] [5] the quality of glycemic control among young patients has not improved dramatically. A significant number of children have suboptimal control of their blood glucose levels, largely reflecting poor selfmanagement practices. [6] [7] [8] [9] [10] [11] This trend is worrisome in that poor glycemic control early in the course of diabetes is associated with significantly increased risks of later morbidity. [12] [13] [14] Mobile technology may be useful in addressing several issues in adolescent diabetes management. We have developed an intervention based on a integrated cell phone glucose monitoring (CPGM) system that automatically transmits self-monitored blood glucose valueswithout further action taken by the user-to a host computer monitored by a health care professional. This enables the provider to identify patterns of glycemic control early and alert the patient before he or she becomes chronically problematic. Moreover, the CPGM system facilitates the user's ability to rapidly interact with the health care provider directly (via phone call or text message) to gain information and discuss therapeutic options. Such technology has several potential advantages. It can help providers monitor glucose value fluctuations and testing frequency and suggest therapeutic options more frequently than what is currently feasible. It also has significant potential to affect the interactions between adolescent and parent, which are often counterproductive to achieving optimal diabetes control. In their efforts to help enforce adaptive regimen behavior, parents frequently try to exert control over their child's behaviors precisely when the adolescent is attempting to achieve more autonomy. Whereas attempting to break from parental authority is developmentally appropriate, it may result in behaviors that are health-jeopardizing for diabetes control, such as decreased frequency of glucose monitoring and omission of insulin doses. Optimizing family-patient interactions is crucial to improving the ability of an adolescent to manage his or her diabetes. 8, 15, 16 We have shown that adolescents with diabetes often feel as though they are being excessively nagged by their parents about self-management in general and selfmonitoring in particular. 17 Similarly, many parents of adolescents with diabetes report feeling as though they are nagging their children, and they see such interactions as a source of conflict within the family. 18 In this context, the cell phone-based technology has the potential to reduce poor self-management that results from parentchild conflict over diabetes therapy behaviors by reducing parental need for hypervigilance (given that the child is being remotely monitored by a health care provider). This also allows the health care provider to take responsibility for "nagging" about diabetes self-management behaviors. Moreover, by observing self-monitoring of blood glucoses in real time, health providers can actively prompt the adolescent to obtain important glucose data. Thus, the technology described here has the capacity to eliminate the need for parental supervision of this task.
The objective of this pilot study was to assess the feasibility of a CPGM system and the extent to which it would be acceptable to adolescents and their parents.
Methods

Participants
Participants were recruited from pediatric and adolescent diabetes clinics at the James Whitcomb Riley Hospital for Children, Indianapolis, Indiana. Eligible patients with type 1 diabetes for at least 1 year between the ages of 13 and 18 were identified from a clinical care database. Eligibility criteria included having grossly normal cognitive development and no other chronic diseases other than diabetes, except well-controlled hypothyroidism or asthma. Adolescents in the study had to intend to remain in the care of participating clinics for the duration of the study (6 months) and be able to read and write in English. Patients who had participated in prior studies related to the development of the cell phone technology were excluded. 19 
Participant Recruitment, Consent, and Incentives
Families of potentially eligible participants were sent a letter about the study, as signed by their diabetes physician and the study's principal investigator, and instructed to call a research assistant if they were interested in participating. The assistant then obtained assent from the patient and consent from the parent. Only 1 child per family could participate. Participating adolescents were remunerated $50 for completing each of 3 evaluationsat baseline, 3 months, and 6 months-for a combined $150. In addition, the study provided the integrated cell phone-glucose meter and provided cellular service for the study duration. The protocol was approved by the Indiana University-Purdue University Indianapolis Institutional Review Board.
Intervention and Procedure
This study utilized the Glucophone™ integrated cell phone and glucose meter (HealthPia USA, Paducah, Kentucky), which has been described elsewhere. 19 As means of summary here, once an individual tests his or her glucose using the CPGM that is part of the cell phone device, the system automatically uploads the glucose measurement via a cellular connection to a host computer. 19 Self-reported insulin administration data are not uploaded. A health care provider can then remotely review the data in this host computer. Each adolescent and his or her parent could also access these online data by logging into the HealthPia Web site. At the time of the baseline study visit, the adolescent and his or her parents met with the nurse practitioner (NP) and were oriented to use of the CPGM. They were provided with an instruction manual on the CPGM device and information on how to contact study personnel should questions arise. Parents and adolescents were instructed to contact the NP if they had a cellular service interruption or had error codes indicating Glucophone™ malfunctions.
In addition, parents were strongly urged to reduce their attempts to enforce self-management behaviornotably, self-monitoring. Instead, they were encouraged to "allow" the adolescent to interact directly with the NP, using the Glucophone™ system as a link, which could be accomplished either by text messaging or by initiating a voice contact via the telephone. During this discussion, we made clear that we were not advocating that parents relinquish all control of diabetes management to the NP who was reviewing their child's self-monitoring behaviors. Rather, we encouraged families to work with the CPGM system and allow the NP provider to assist the adolescent in developing a more effective and consistent glycemic monitoring pattern. In this regard, parents were strongly encouraged to try to curb their "nagging" about self-monitoring. All adolescents were included in these discussions and were similarly encouraged to hold up their "end of the bargain" by self-monitoring their blood glucose following a negotiated schedule. Letters were provided to alert schools that the phones were medical devices and would need to be permitted during the day.
All available uploaded blood glucose data were reviewed daily by the NP, using a specially designed computer software program. This program included a predetermined prompting algorithm (Table 1) designed to identify blood glucose patterns that needed to be addressed to reduce potential acute and chronic problems. This algorithm guided the need for and frequency of telephone contacts initiated by the NP to the participant. Depending on the quality of the transmitted data, patients might be telephoned or sent a text message by the NP to discuss recent blood glucose values, offer possible regimen adjustments, or suggest additional contacts. When there was no response to the initial text, a followup text or phone call would be made. The algorithm stated that a parent would be notified if the NP remained unable to contact the adolescent. However, at no time during the study period did a parent need to be notified for adolescent nonresponse. All insulin adjustments were made by the NP using dose-adjustment algorithms developed by the principal investigator and participating pediatric endocrinologists. Although telephone or text message contacts were made directly with the adolescent, parents were notified of this information by e-mail or telephone. Participants whose data were within the algorithm parameters were also contacted by phone or text message to praise them for maintaining positive selfmanagement behaviors and good glycemic control.
All participants attended the diabetes clinic for routine care with their usual pediatric endocrinologist and other members of the diabetes team approximately 3 months and 6 months after enrollment.
Outcome Measures
The primary outcome of this study was the usability of and satisfaction with the CPGM system. The secondary outcomes were measures of how use of the system might affect quality of family functioning and diabetes management.
To assess the primary outcome, a survey was administered to the adolescents and one of their parents at the end of the study. We asked 6 to 10 questions in each of 4 domains: the phone device and the HealthPia Company, the cellular phone / text message service, the study procedures, and perceptions about how the phone affected the home diabetes management. Surveys were filled out by participants and parents and took less than 10 minutes to complete. For the first 3 domains, the questions for adolescents and parents were identical; for the fourth, questions were tailored to 1 of these 2 groups. Answers were in the form of a Likert-type scale: strongly agree, agree, neutral, disagree, strongly disagree. For the purposes of analyses, we grouped the 2 agree and disagree categories together.
Analysis
The primary analysis was a description of the percentage of participants and parents who agreed with the statements in the survey.
Results
Over the 6-month period, 40 patients were enrolled in the study. One patient was asked to withdraw from the study after it was discovered that she had a chronic condition that met exclusion criteria. The remaining 39 patients completed all study surveys. Of these, 19 were girls and 20 were boys; baseline average hemoglobin A1C was 8.7%. Four patients were asked to stop using the Glucophone™ during the study. One was discontinued owing to repeated overages on her text-messaging allowance. Three decided that they no longer wanted to use the Glucophone™: 1 because of concerns about meter accuracy and the other 2 because of the hassles of remaining under the monitoring protocol. All, however, were asked to complete the surveys at all data collection times. Table 2 presents user-reported activities that relate to technical issues that occurred with the devices and subsequent interactions with HealthPia Company (producer of Glucophone™). These data illuminate the technical issues that can arise when a new product is introduced. Because the company that provided cellular service for the Glucophone™ did not have uniform cell phone service, particularly in rural areas, several of the adolescents had issues with cellular service interruptions when they were in "dead zones." This meant that they had to travel with their phones to a serviced area for data to upload. About a third of participants reported having to contact the company over the course of the study for customer service issues. Moreover, about three-quarters reported having to send the phones back to the company at some point during the study for service. Only about half found the Web-based monitoring service to be easy to follow and helpful. Almost three-quarters thought that the meter was accurate, and two-thirds thought that the amount of blood needed was not a problem.
User-reported activities relating to the LogicMobile cellular service are reported in Table 3 . Fewer participants reported having to contact the cellular service company than the Glucophone™ company. Most participants thought that the text messaging (600 per month) and minutes (450 per month) provided were adequate. Although somewhere between a third and a half reported some Same scheduled blood glucose measurement is < 60 mg/dL 2 days in a row disruption of service over the course of the study, it did not appear to affect usage or desirability of the system. Most participants reported liking the combination of the cell phone and glucose meter in one device, and three-quarters reported that they would switch from a normal phone to such a device if it were available from their physician. Table 4 presents user-reported feelings about the study procedures. Nearly all participants felt that other adolescents with diabetes would want to participate in a study like this. Nearly all participants thought that the amount of contact they had with the NP was exactly right. Over half of participants thought that the use of the Glucophone™ made them better at reading their body cues. Few participants reported that their schools had concerns about allowing them to carry and use the Glucophone™ devices in school. Table 5 presents adolescent-reported activities and feelings about the Glucophone™. Very few adolescents reported actually increasing their blood glucose testing because of the Glucophone™. Anecdotally, text messages from the NP were reported to have this effect. Most adolescents reported being more independent in their diabetes management because of the Glucophone™ and wanted to use it after the study if they could. Table 6 presents parent-reported activities and feelings about the Glucophone™. Like the adolescents, parents had reasonably positive feelings about the Glucophone™ and the study. Most thought that it was helpful in managing their child's diabetes and would continue using the phone if possible. Almost 80% believed that it removed some burden from worrying about such management, and they liked their child using it. About two-thirds thought that their adolescent's health benefited as a direct result of the Glucophone™.
Conclusions
This study found that the novel Glucophone™ CPGM system was well received by adolescents with diabetes and their parents. Participants reported positive feelings about the technology and the service, even though a concerning number of them had significant issues with the phone, many requiring exchanges over the 6-month period. Nearly all thought that the clinic involvement in monitoring testing behavior was perfectly acceptable. Moreover, many reported that they saw potential in the technology. Adolescents thought that it might improve their self-management, and parents thought that it might alleviate their concerns and burdensome feelings because of their child's management.
On average, 2 hours of time was spent daily to text the adolescents in response to the flags that the software system created. Call time was minimal because it was the backup plan to the text communication option. However, calling did occur because complex dose changes were often too difficult to send in a text message. Most often, text messages were not responded to immediately, because the adolescents were in school; therefore, another hour of time was spent in the evenings responding to text messages from the initial daily round of texting. In addition, about 2 more hours were spent daily updating electronic medical records with insulin doses, updating clinic charts, and notifying the parents' of the dose changes.
This study, like all research, had limitations that warrant consideration. The gaps in service and technology shortfalls were significant and need further work. A relatively small sample was studied, with the intention of showing the feasibility of the technology; therefore, the study was not designed to examine questions that could be answered in a larger study. This was also a study that lacked a well-established integration of the phone system into the entirety of clinical care. That a NP was making therapy adjustments outside of normal practices is not normative in the clinical environment in which the study was conducted. Therefore, integration of this management into all aspects of care might yield different results.
As a feasibility study of the technology, this work was successful in demonstrating that CPGM technology can be used in an adolescent population. At the end of the study protocol, nearly all the adolescents requested to Table 6 Parent-Reported Activities and Feelings About the Glucophone™ Parents Agreeing, %
The Glucophone™ was helpful in managing my child's diabetes. 63 I am pleased with the progress my child has made in caring for himself/herself, as a direct result of participating in this study. 63 I would use this device in my child's care, if it was covered by insurance. 80 Knowing that my child had the Glucophone™ with them, helped me feel more at ease and alleviated some of the burden of caring for a teenager with diabetes. 79 I believe my child is better capable of recognizing his/her own blood sugar trends, as a direct result of participating in this study. 67 I would allow my child to use the Glucophone™, if he/she could use it with our family's cell phone service. 80 My child's health benefitted as a direct result of his/her use of the Glucophone™. 63 In general, I liked having my child use the Glucophone™. 80
keep the phones and continue using them. Future work, however, needs to demonstrate that CPGM improves management decisions or glycemic control. Although it is possible that it will be difficult to readily incorporate this technology into clinics as a way of improving care of children with diabetes, we do not believe that this will be the case, based on our prior work showing that CPGM is well suited to adolescent management of diabetes. [18] [19] [20] It is more likely that as an isolated extra component of diabetes care without additional behavior changes, this technology and its potential cannot be fully exploited.
We speculate that explicitly attempting to change behavior, perhaps with the use of behavioral contracts, will enhance the ability of the technology to be a tool to improve outcomes. We have already begun work on developing such a contract, and we believe that employing it in a more integrated clinical setting might finally allow us to capitalize on this technology to improve care for adolescents with diabetes.
